• International
  • Albania
  • Bosnia and Herzegovina
  • Bulgaria
  • Croatia
  • Czech Republic
  • Estonia
  • Hungary
  • Latvia
  • Lithuania
  • Kosovo
  • North Macedonia
  • Poland
  • Romania
  • Serbia
  • Slovakia
  • Slovenia
  • Switzerland (German)
  • Switzerland (French)
  • Media
  • Meet us
  • Careers
  • Contact
ewopharma
  • Business Development
    • Licensing
    • Strategic Therapeutic Areas
    • Territory
  • Partners & Brands
    • Testimonials
  • About Ewopharma
    • Vision/Mission
    • Our Values
    • Our Strategy
    • Leadership
    • Corporate Responsibility
    • Territory
  • Media
  • Meet us
  • Careers
  • Contact
  • International
  • Albania
  • Bosnia and Herzegovina
  • Bulgaria
  • Croatia
  • Czech Republic
  • Estonia
  • Hungary
  • Latvia
  • Lithuania
  • Kosovo
  • North Macedonia
  • Poland
  • Romania
  • Serbia
  • Slovakia
  • Slovenia
  • Switzerland (German)
  • Switzerland (French)
 

Media

Our Logo

Download Logo

CONTACT

Ewopharma AG
Vordergasse 43
8200 Schaffhausen
Switzerland

Tel.: +41 52 633 09 99
E-Mail: pr@remove-this.ewopharma.com

PRESS RELEASES

  • Previous
  • 1
  • 2
  • 3
  • 4
  • Next
31.05.2023

Neomed s.r.o. becomes part of Ewopharma Group

Read more
29.04.2022

Calmino and Ewopharma join up to treat Irritable Bowel Syndrome (IBS)

Read more
17.05.2021

Neobiomics AB and Ewopharma AG announce an exclusive collaboration for distribution of ProPrems® in Switzerland

Read more
16.03.2021

Can-Fite Signs $42.7 Million Out-Licensing Deal with Ewopharma

Read more
23.10.2020

Acar’Up and Ewopharma join the fight against dust mite allergy by launching ExAller®

Read more
  • Previous
  • 1
  • 2
  • 3
  • 4
  • Next

Ewopharma AG
Vordergasse 43
8200 Schaffhausen
Switzerland

CONTACT

Phone: +41 52 633 09 99
E-mail:  info@remove-this.ewopharma.com

Contact for reporting side effects:

pharmacovigilance@remove-this.ewopharma.com

  • Privacy Policy
  • Cookie Policy
  • Imprint
  • VPOIS

© Copyright 2022, Ewopharma AG